Please assess the completion status of the following clinical trial:

Trial Title: Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Healthy male or female infant between, and including, 6 and 12 weeks of age born after a gestation period of 36 to 42 weeks or a birth weight of \>2000g.~* Written informed consent obtained from the parent or guardian of the subject.~Exclusion Criteria:~* Planned administration of oral polio vaccine during the period starting from 2 weeks before each dose of study vaccine(s) and ending 2 weeks after.~* Any confirmed or suspected immunosuppressive or immunodeficient condition, including human immunodeficiency virus (HIV) infection~* History of diphtheria, tetanus, pertussis, Hib disease and/ or hepatitis B.~* Previous vaccination against diphtheria, tetanus, pertussis, and/or Haemophilus influenzae type b.~* History of allergic disease~* Any clinically significant history of chronic gastrointestinal disease including any uncorrected congenital malformation of the GI tract or other serious medical condition as determined by the investigator.~* Gastroenteritis within 7 days preceding the study vaccine administration (warrants deferral of the vaccination)~* Previous confirmed occurrence of RV GE.~* Household contact with an immunosuppressed individual or pregnant women.~* Administration of immunoglobulins and/or blood products since birth or planned administration during the study period

- Gender: ALL
- Minimum Age: 6 Weeks
- Maximum Age: 12 Weeks
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).